BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 35307512)

  • 21. Stool DNA methylation assays in colorectal cancer screening.
    Kadiyska T; Nossikoff A
    World J Gastroenterol; 2015 Sep; 21(35):10057-61. PubMed ID: 26401070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple Biomarker-Combined Screening for Colorectal Cancer Based on Bisulfate Conversion-Free Detection of Fecal DNA Methylation.
    Liu C; Xu L; Li W; Jie M; Xue W; Yu W
    Biomed Res Int; 2021; 2021():1479748. PubMed ID: 34621892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
    Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using Comorbidity Pattern Analysis to Detect Reliable Methylated Genes in Colorectal Cancer Verified by Stool DNA Test.
    Cheng YC; Wu PH; Chen YJ; Yang CH; Huang JL; Chou YC; Chang PK; Wen CC; Jao SW; Huang HH; Tsai YH; Pai TW
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of combined detection of multigene mutation and SDC2/SFRP2 methylation in stool specimens for colorectal cancer early diagnosis.
    Lin J; Zhang L; Chen M; Chen J; Wu Y; Wang T; Lu Y; Ba Z; Cheng X; Xu R; Tian T; Sun A; Zhang T; Chen M
    Int J Colorectal Dis; 2022 Jun; 37(6):1231-1238. PubMed ID: 35499710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples.
    Barták BK; Kalmár A; Péterfia B; Patai ÁV; Galamb O; Valcz G; Spisák S; Wichmann B; Nagy ZB; Tóth K; Tulassay Z; Igaz P; Molnár B
    Epigenetics; 2017 Sep; 12(9):751-763. PubMed ID: 28753106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer.
    Perez-Carbonell L; Balaguer F; Toiyama Y; Egoavil C; Rojas E; Guarinos C; Andreu M; Llor X; Castells A; Jover R; Boland CR; Goel A
    PLoS One; 2014; 9(8):e104285. PubMed ID: 25127039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detecting colorectal cancer using genetic and epigenetic biomarkers: screening and diagnosis.
    Rezkitha YAA; Panenggak NSR; Lusida MI; Rianda RV; Mahmudah I; Pradana AD; Uchida T; Miftahussurur M
    J Med Life; 2024 Jan; 17(1):4-14. PubMed ID: 38737656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal Cancer Early Detection in Stool Samples Tracing CpG Islands Methylation Alterations Affecting Gene Expression.
    Vega-Benedetti AF; Loi E; Moi L; Orrù S; Ziranu P; Pretta A; Lai E; Puzzoni M; Ciccone L; Casadei-Gardini A; Cabras F; Fortunato F; Restivo A; Zorcolo L; Scartozzi M; Zavattari P
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
    Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
    Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic evaluation of stool DNA preparation protocols for colorectal cancer screening via analysis of DNA methylation biomarkers.
    Jin S; Ye Q; Hong Y; Dai W; Zhang C; Liu W; Guo Y; Zhu D; Zhang Z; Chen S; Wang Y; Li D; Ma W; Yang Z; Li J; Zheng Z; Luan J; Wu X; Jiang F; Xu C; Ding C
    Clin Chem Lab Med; 2020 Jul; 59(1):91-99. PubMed ID: 32673280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stage-differentiated ensemble modeling of DNA methylation landscapes uncovers salient biomarkers and prognostic signatures in colorectal cancer progression.
    Muthamilselvan S; Raghavendran A; Palaniappan A
    PLoS One; 2022; 17(2):e0249151. PubMed ID: 35202405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assimilating Epigenetics and Transcriptomics for the Identification of Prognostic Novel Biomarkers and Imminent Targets in Colorectal Carcinoma with Therapeutic Potential.
    Ray SK; Mukherjee S
    Curr Mol Med; 2023; 23(8):784-798. PubMed ID: 35546765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
    Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
    Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative detection of SRY-Box 21 (
    Moradi K; Babaei E; Hosseinpour Feizi MA; Safaralizadeh R; Rezvani N
    Indian J Cancer; 2021; 58(2):217-224. PubMed ID: 33402569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fecal DNA methylation markers for detecting stages of colorectal cancer and its precursors: a systematic review.
    Raut JR; Guan Z; Schrotz-King P; Brenner H
    Clin Epigenetics; 2020 Aug; 12(1):122. PubMed ID: 32778176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine.
    Fatemi N; Tierling S; Es HA; Varkiani M; Mojarad EN; Aghdaei HA; Walter J; Totonchi M
    Int J Cancer; 2022 Dec; 151(12):2068-2081. PubMed ID: 35730647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review.
    Draht MXG; Goudkade D; Koch A; Grabsch HI; Weijenberg MP; van Engeland M; Melotte V; Smits KM
    Clin Epigenetics; 2018; 10():35. PubMed ID: 29564023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A network-based, integrative approach to identify genes with aberrant co-methylation in colorectal cancer.
    Li Y; Xu J; Ju H; Xiao Y; Chen H; Lv J; Shao T; Bai J; Zhang Y; Wang L; Wang X; Ren H; Li X
    Mol Biosyst; 2014 Feb; 10(2):180-90. PubMed ID: 24317156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
    Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
    World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.